A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 May 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov
- 04 Sep 2005 New trial record.